Pathoma Deck Flashcards

1
Q

Rinitis

A

A. Inflammation of the nasal mucosa; rhinovirus is the most common cause
B. Presents with sneezing, congestion, and runny nose (common cold)
c. allergic rhinitis is a subtype of rhinitis due to a type 1 hypersensitivity reaction (e.g. pollen); characterized by an inflammatory infiltrate with eosinophils; associated with asthma and eczema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Nasal Polyp

A

A. Protrusion of edematous, inflamed nasal mucosa
B. Usually secondary to repeated bouts of rhinitis; also occurs in cystic fibrosis and
aspirin-intolerant asthma
1. Aspirin-intolerant asthma is characterized by the triad of asthma, aspirin-
induced bronchospasms, and nasal polyps; seen in 10% of asthmatic adults

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Angiofibroma

A

A. Benign tumor of nasal mucosa composed of large blood vessels and fibrous tissue;
classically seen in adolescent males B. Presents with profuse epistaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Nasopharyngeal carcinoma

A

A. Malignant tumor of nasopharyngeal epithelium
B. Associated with EBV; classically seen in African children and Chinese adults
C. Biopsy usually reveals pleomorphic keratin-positive epithelial cells (poorly
differentiated squamous cell carcinoma) in a background of lymphocytes. D. Often presents with involvement of cervical lymph nodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Acute epiglottitis

A

A. Inflammation of the epiglottis (Fig. 9.1); H influenzae type b is the most common
cause, especially in nonimmunized children. B. Presents with high fever, sore throat, drooling with dysphagia, muffled voice, and
inspiratory stridor; risk of airway obstruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Croup (laryngotracheobronchitis)

A

A. Inflammation of the upper airway; parainfluenza virus is the most common cause.
B. Presents with a hoarse, “barking” cough and inspiratory stridor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Vocal cord nodule (singer’s nodule)

A

A. Nodule that arises on the true vocal cord
B. Due to excessive use of vocal cords; usually bilateral (Fig. 9.2A)
1. Composed of degenerative (myxoid) connective tissue (Fig. 9.2B)
C. Presents with hoarseness; resolves with resting of voice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Laryngeal papilloma

A

A. Benign papillary tumor of the vocal cord
B. Due to HPV 6 and 11; papillomas are usually single in adults and multiple in
children. C. Presents with hoarseness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

laryngeal carcinoma

A

A. Squamous cell carcinoma usually arising from the epithelial lining of the vocal cord
B. Risk factors are alcohol and tobacco; can rarely arise from a laryngeal papilloma
C. Presents with hoarseness; other signs include cough and stridor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

pneumonia

A

A. Infection of the lung parenchyma
B. Occurs when normal defenses are impaired (e.g., impaired cough reflex, damage to
mucociliary escalator, or mucus plugging) or organism is highly virulent. C. Clinical features include fever and chills, productive cough with yellow-green (pus)
or rusty (bloody) sputum, tachypnea with pleuritic chest pain, decreased breath
sounds, crackles, dullness to percussion, and elevated WBC count. D. Diagnosis is made by chest x-ray, sputum gram stain and culture, and blood
cultures. E. Three patterns are classically seen on chest x-ray: lobar pneumonia,
bronchopneumonia, and interstitial pneumonia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

lobar pneumonia

A

A. Characterized by consolidation of an entire lobe of the lung (Fig. 9.3A)
B. Usually bacterial; most common causes are Streptococcus pneumoniae (95%) and
Klebsiella pneumoniae (Table 9.1) C. Classic gross phases of lobar pneumonia
1. Congestion - due to congested vessels and edema 2. Red hepatization - due to exudate, neutrophils, and hemorrhage filling the alveolar
air spaces, giving the normally spongy lung a solid consistency (Fig. 9.3B,C) 3. Gray hepatization - due to degradation of red cells within the exudate 4. Resolution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

bronchopneumonia

A

A. Characterized by scattered patchy consolidation centered around bronchioles; often
multifocal and bilateral (Fig. 9.4) B. Caused by a variety of bacterial organisms (Table 9.2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Interstitial pneumonia

A

A. Characterized by diffuse interstitial infiltrates (Fig. 9.5)
B. Presents with relatively mild upper respiratory symptoms (minimal sputum and low
fever); ‘atypical’ presentation C. Caused by bacteria or viruses (Table 9.3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

aspiration pneumonia

A

A. Seen in patients at risk for aspiration (e.g., alcoholics and comatose patients)
B. Most often due to anaerobic bacteria in the oropharynx (e.g., Bacteroides,
Fusobacterium, and Peptococcus); C. Classically results in a right lower lobe abscess
1. Anatomically, the right main stem bronchus branches at a less acute angle than
the left

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

strep pneumonia

A

Cause of lobar pneumonia; Most common cause of community-acquired pneumonia and secondary Streptococcus pneumoniae
pneumonia (bacterial pneumonia superimposed on a viral upper respiratory tract infection); usually seen in middle-aged adults and elderly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

klebisella pneumoniae

A

cause of lobar pneumonia; Enteric flora that is aspirated; affects malnourished and debilitated individuals,
especially elderly in nursing homes, alcoholics, and diabetics. Thick mucoid capsule results in gelatinous sputum (currant jelly); often complicated by abscess

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

staph. aureus

A

cause bronchopneumonia;
2ndmost common cause of secondary pneumonia; often complicated by abscess or empyema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

h. influenzae

A

cause of bronchopneumonia; common cause of secondary pneumonia and pneumonia superimposed on COPD (leads to exacerbation of COPD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

pseudomonas aeruginosa

A

cause of bronchopneumonia; pneumonia in cystic fibrosis patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

moraxella catarhalis

A

cause of bronchopneumonia; community -acquired pneumonia superimposed on COPD (leads to exacerbation of COPD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Legionella pneumophila

A

cause of bronchopneumonia; Community-acquired pneumonia, pneumonia superimposed on COPD, or Legionella pneumophila
pneumonia in immunocompromised states; transmitted from water source Intracellular organism that is best visualized by silver stain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

mycoplasma pneumoniae

A

Most common cause of atypical (interstitial) pneumonia, usually affects young adults (classically, military recruits or college students living in a dormitory). Complications include autoimmune hemolytic anemia (IgM against I antigen on RBCs causes cold hemolytic anemia) and erythema multiforme. Not visible on gram stain due to lack of cell wall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

chlamydia pneumoniae

A

Second most common cause of atypical (interstitial) pneumonia in young adults

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Respiratory syncytial virus (RSV)

A

Most common cause of atypical (interstitial) pneumonia in infants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Cytomegalovirus (CMV)

A

Atypical (interstitial) pneumonia with posttransplant immunosuppression or chemotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Influenza virus

A

Atypical pneumonia in the elderly, immunocompromised, and those with preexisting lung disease. Also increases the risk for superimposed S aureus or H influenzae bacterial pneumonia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

coxiella brunetti

A

Atypical (interstitial) pneumonia with high fever (Q fever); seen in farmers and veterinarians ( Coxiella spores are deposited on cattle by ticks or are present in cattle placentas). Coxiella is a rickettsial organism, but it is distinct from most rickettsiae because it (1) causes pneumonia, (2) does not require arthropod vector for transmission (survives as highly heat-resistant endospores), and (3) does not produce a skin rash.

28
Q

Tuberculosis

A

Due to inhalation of aerosolized Mycobacterium tuberculosis

29
Q

Primary TB arises with initial exposure

A

Results in focal, caseating necrosis in the lower lobe of the lung and hilar lymph
nodes that undergoes fibrosis and calcification, forming a Ghon complex (Fig. 9.6A)
2. Primary TB is generally asymptomatic, but leads to a positive PPD.

30
Q

secondary TB arises with reactivation of mycobacterium tb

A
  1. Reactivation is commonly due to AIDS; may also be seen with aging
  2. Occurs at apex of lung (relatively poor lymphatic drainage and high oxygen
    tension) 3. Forms cavitary foci of caseous necrosis; may also lead to miliary pulmonary TB
    or tuberculous bronchopneumonia 4. Clinical features include fevers and night sweats, cough with hemoptysis, and
    weight loss. 5. Biopsy reveals caseating granulomas; AFB stain reveals acid-fast bacilli (Fig.
    9.6B,C). 6. Systemic spread often occurs and can involve any tissue; common sites include
    meninges (meningitis), cervical lymph nodes, kidneys (sterile pyuria), and
    lumbar vertebrae (Pott disease).
31
Q

COPD basic principles

A

A. Group of diseases characterized by airway obstruction; lung does not empty, and air
is trapped.
1. Volume of air that can be forcefully expired is decreased (
↓FVC), especially
during the first second of expiration (↓↓FEV1); results in ↓FEV1:FVC ratio 2. Total lung capacity (TLC) is usually increased due to air trapping.

32
Q

chronic bronchitis

A

obstructive; A. Chronic productive cough lasting at least 3 months over a minimum of 2 years;
highly associated with smoking B. Characterized by hypertrophy of bronchial mucous glands (Fig. 9.7)
1. Leads to increased thickness of mucus glands relative to bronchial wall thickness
(Reid index increases to > 50%; normal is < 40%).
C. Clinical features
1. Productive cough due to excessive mucus production
2. Cyanosis (‘blue bloaters’) - Mucus plugs trap carbon dioxide; ↑Paco2
and ↓ Pa o2 3. Increased risk of infection and cor pulmonale

33
Q

emphysema

A

. Destruction o f alveolar air sacs (Fig. 9.8)
1. Loss of elastic recoil and collapse of airways during exhalation results in
obstruction and air trapping.

34
Q

emphysema cause

A

Due to imbalance o f proteases and antiproteases
1. Inflammation in the lung normally leads to release o f proteases by neutrophils
and macrophages. 2. α 1-antitrypsin (A1AT) neutralizes proteases. 3. Excessive inflammation or lack of A1AT leads to destruction of the alveolar air
sacs.
C. Smoking is the most common cause of emphysema.
1. Pollutants in smoke lead to excessive inflammation and protease-mediated
damage.2. Results in centriacinar emphysema that is most severe in the upper lobes

35
Q

A1AT deficiency

A

D. A1AT deficiency is a rare cause of emphysema.
1. Lack of antiprotease leaves the air sacs vulnerable to protease-mediated damage.
2. Results in panacinar emphysema that is most severe in the lower lobes
3. Liver cirrhosis may also be present.
i. A l AT deficiency is due to misfolding of the mutated protein. ii. Mutant A1AT accumulates in the endoplasmic reticulum of hepatocytes,
resulting in liver damage. iii. Biopsy reveals pink, PAS-positive globules in hepatocytes (Fig. 9.9).

36
Q

Emphysema disease severity

A
  1. Disease severity is based on the degree o f AlAT deficiency.
    i. PiM is the normal allele; two copies are usually expressed (PiMM).
    ii. PiZ is the most common clinically relevant mutation; results in significantly
    low levels o f circulating A1AT
    iii. PiMZ heterozygotes are usually asymptomatic with decreased circulating
    levels of A1AT; however, significant risk for emphysema with smoking
    exists. iv. PiZZ homozygotes are at significant risk for panacinar emphysema and
    cirrhosis.
37
Q

Emphysema clinical features

A

E. Clinical features of emphysema include
1. Dyspnea and cough with minimal sputum
2. Prolonged expiration with pursed lips (‘pink-puffer’)
3. Weight loss
4. Increased anterior-posterior diameter of chest (‘barrel-chest,’ Fig. 9.10)
5. Hypoxemia (due to destruction of capillaries in the alveolar sac) and cor
pulmonale are late complications.

38
Q

Asthma pathogenesis

A

A. Reversible airway bronchoconstriction, most often due to allergic stimuli (atopic asthma)
B. Presents in childhood; often associated with allergic rhinitis, eczema, and a family
history of atopy C. Pathogenesis (type I hypersensitivity)
1. Allergens induce TH2 2. phenotype in CD4 + T cells of genetically susceptible individuals. 3. T H2 cells secrete IL-4 (mediates class switch to IgE), IL-5 (attracts eosinophils),
and IL-10 (stimulates T H2 cells and inhibits TH1). 4. Reexposure to allergen leads to IgE-mediated activation of mast cells.
i. Release of preformed histamine granules and generation of leukotrienes C4,
D4, and E4 lead to bronchoconstriction, inflammation, and edema (early- phase reaction).
ii. Inflammation, especially major basic protein derived from eosinophils,
damages cells and perpetuates bronchoconstriction (late-phase reaction).

39
Q

asthma clinical features

A

D. Clinical features are episodic and related to allergen exposure.
1. Dyspnea and wheezing
2. Productive cough, classically with spiral-shaped mucus plugs (Curschmann
spirals) and eosinophil-derived crystals (Charcot-Leyden crystals, Fig. 9.11). 3. Severe, unrelenting attack can result in status asthmaticus and death.
E. Asthma may also arise from nonallergic causes (non-atopic asthma) such as exercise, viral infection, aspirin (e.g., aspirin intolerant asthma), and occupational exposures.

40
Q

Bronchiectasis causes

A

A. Permanent dilatation of bronchi (Fig. 9.12); loss of airway tone results in air trapping.
B. Due to severe inflammation with damage to airway walls. Causes include
1. Cystic fibrosis 2. Primary ciliary dyskinesia - inherited defect of the dynein arm, which is
necessary for ciliary movement. Associated with sinusitis, infertility (poor
motility of sperm), and situs inversus (position of major organs is reversed, e.g.,
heart is on right side of thorax), which is called Kartagener syndrome
3. Tumor or foreign body (localized bronchiectasis) 4. Necrotizing infection (localized bronchiectasis) 5. Allergic bronchopulmonary aspergillosis - Hypersensitivity reaction to
Aspe rgillus leads to chronic inflammatory damage; usually seen in individuals
with asthma or cystic fibrosis

41
Q

bronchiectasis clinical features

A
  1. Cough, dyspnea, and foul-smelling sputum
  2. Complications include hypoxemia with cor pulmonale and secondary (AA)
    amyloidosis.
42
Q

restrictive disease basic principles

A

A. Characterized by restricted filling of the lung; ↓TLC, ↓FEV1, and↓↓FVC;
FEV1:FVC ratio is increased.
B. Most commonly due to interstitial diseases of the lung; may also arise with chest
wall abnormalities (e.g., massive obesity)

43
Q

idiopathic pulmonary fibrosis

A

restrictive; A. Fibrosis of lung interstitium (Fig. 9.13)
B. Etiology is unknown. Likely related to cyclical lung injury; TGF-β from injured
pneumocytes induces fibrosis.
1. Secondary causes of interstitial fibrosis such as drugs (e.g., bleomycin and
amiodarone) and radiation therapy must be excluded.

44
Q

idiopathic pulmonary fibrosis clinical features

A
  1. Progressive dyspnea and cough
  2. Bilateral fibrosis on lung CT; initially seen in subpleural patches, but eventually
    results in extensive fibrosis with end-stage ‘honeycomb’ lung 3. Anti-fibrogenic drugs slow disease progression 4. Definitive treatment is lung transplantation.
45
Q

pneumoconioses

A

A. Interstitial fibrosis due to occupational exposure; requires chronic exposure to small
particles that are fibrogenic (Table 9.4)
1. Alveolar macrophages engulf foreign particles and induce fibrosis.

46
Q

sarcoidosis

A

A. Systemic disease characterized by noncaseating granulomas in multiple organs;
classically seen in African American females
B. Etiology is unknown; likely due to CD4+ helper T-cell response to an unknown
antigen C. Granulomas most commonly involve the hilar lymph nodes and lung (Fig. 9.15A),
leading to restrictive lung disease.
1. Characteristic stellate inclusions (‘asteroid bodies’) are often seen within giant
cells o f the granulomas (Fig. 9.15B).
D. Other commonly involved tissues include the uvea (uveitis), skin (cutaneous
nodules or erythema nodosum), and salivary and lacrimal glands (mimics Sjögren
syndrome); almost any tissue can be involved.

47
Q

clinical features of sarcoidosis

A

E. Clinical features
1. Dyspnea or cough (most common presenting symptom) 2. Elevated serum ACE 3. Hypercalcemia (1-alpha hydroxylase activity o f epithelioid histiocytes converts
vitamin D to its active form) 4. Treatment is immunosuppression; often resolves spontaneously without
treatment.

48
Q

Summary of pneumoconiosis: coal worker’s, silicosis, berylliosis, asbestosis

A
49
Q

hypersensitivity pneumonitis

A

restrictive; A. Granulomatous reaction to inhaled organic antigens (e.g., pigeon breeder’s lung)
B. Presents with fever, cough, and dyspnea hours after exposure; resolves with removal
of the exposure C. Chronic exposure leads to interstitial fibrosis.

50
Q

pulmonary hypertension basic principles

A

A. High pressure in the pulmonary circuit (mean arterial pressure > 25 mm Hg; normal
is 10 mm Hg) B. Characterized by atherosclerosis of the pulmonary trunk, smooth muscle
hypertrophy of pulmonary arteries, and intimal fibrosis; plexiform lesions are seen
with severe, long-standing disease (Fig. 9.16). C. Leads to right ventricular hypertrophy with eventual cor pulmonale D. Presents with exertional dyspnea or right-sided heart failure E. Subclassified as primary or secondary based on etiology

51
Q

primary pulmonary hypertension

A

A. Classically seen in young adult females
B. Etiology is unknown; some familial forms are related to inactivating mutations of
BMPR2, leading to proliferation of vascular smooth muscle.

52
Q

secondary pulmonary hypertension

A

A. Due to hypoxemia (e.g., COPD and interstitial lung disease) or increased volume in
the pulmonary circuit (e.g., congenital heart disease); may also arise with recurrent pulmonary embolism

53
Q

Acute respiratory distress syndrome

A

A. Diffuse damage to the alveolar-capillary interface (diffuse alveolar damage)
B. Leakage of protein-rich fluid leads to edema that combines with necrotic epithelial
cells to form hyaline membranes lining alveoli (Fig. 9.17A).

54
Q

acute respiratory distress syndrome clinical features

A

Clinical features
1. Hypoxemia and cyanosis with respiratory distress - due to thickened diffusion
barrier and collapse of air sacs (increased surface tension) 2. ‘White-out’ on chest x-ray (Fig. 9.17B)D. Secondary to a variety of disease processes including sepsis, infection, shock, trauma, aspiration, pancreatitis, DIC, hypersensitivity reactions, and drugs.

55
Q

Treatment of acute RDS

A

Treatment
1. Address underlying cause
2. Ventilation with positive end-expiratory pressure (PEEP) F. Recovery may be complicated by interstitial fibrosis; damage and loss of type II
pneumocytes leads to scarring and fibrosis.

56
Q

neonatal RDS

A

Respiratory distress due to inadequate surfactant levels
1. Surfactant is made by type II pneumocytes; phosphatidylcholine (lecithin) is the
major component. 2. Surfactant decreases surface tension in the lung, preventing collapse of alveolar
air sacs after expiration. 3. Lack of surfactant leads to collapse of air sacs and formation of hyaline
membranes.

57
Q

neonatal RDS associations

A

B. Associated with
1. Prematurity - Surfactant production begins at 28 weeks; adequate levels are not
reached until 34 weeks. i. Amniotic fluid lecithin to sphingomyelin ratio is used to screen for lung
maturity. ii. Phosphatidylcholine (lecithin) levels increase as surfactant is produced;
sphingomyelin remains constant. iii. A ratio > 2 indicates adequate surfactant production.
2. Caesarian section delivery - due to lack of stress-induced steroids; steroids
increase synthesis of surfactant. 3. Maternal diabetes - Insulin decreases surfactant production.

58
Q

neonatal RDS clinical features

A
  1. Increasing respiratory effort after birth, tachypnea with use of accessory muscles,
    and grunting 2. Hypoxemia with cyanosis 3. Diffuse granularity of the lung (‘ground-glass’ appearance) on x-ray (Fig. 9.18)
59
Q

neonatal RDS complications

A
  1. Hypoxemia increases the risk for persistence of patent ductus arteriosus and
    necrotizing enterocolitis. 2. Supplemental oxygen increases the risk for free radical injury. Retinal injury
    leads to blindness; lung damage leads to bronchopulmonary dysplasia.
60
Q

lung cancer basic principles

A

A. Most common cause of cancer mortality in the US; average age at presentation is 60
years. B. Key risk factors are cigarette smoke, radon, and asbestos.
1. Cigarette smoke contains over 60 carcinogens; 85% of lung cancer occurs in
smokers.
i. Polycyclic aromatic hydrocarbons and arsenic are particularly mutagenic.
ii. Cancer risk is directly related to the duration and amount of smoking
(‘pack-years’). 2. Radon is formed by radioactive decay of uranium, which is present in soil.
i. Accumulates in closed spaces such as basements ii. Responsible for most of the public exposure to ionizing radiation; 2nd most
frequent cause of lung carcinoma in US
iii. Increased risk of lung cancer is also seen in uranium miners. 3. Environmental toxins include asbestos, coal fueled stoves, and metals (arsenic,
chromium, and nickel)
C. Presenting symptoms are nonspecific (e.g., cough, hemoptysis, dyspnea, weight loss,
and post-obstructive pneumonia).

61
Q

lung cancer imaging

A

D. Imaging usually reveals a large, spiculated mass; however, a solitary nodule (‘coin-
lesion’) can be seen. Biopsy is necessary for a diagnosis of cancer.
1. Benign lesions may also produce a ‘coin-lesion,’ especially in younger patients.
Examples include
i. Granuloma - often due to TB or fungus (especially Histoplasma in the Midwest)
ii. Bronchial hamartoma - benign tumor composed of lung tissue and cartilage;
often calcified on imaging

62
Q

lung cancer classifications

A

E. Lung carcinoma is classically divided into 2 categories (Table 9.5).
1. Small cell carcinoma (15%) - usually not amenable to surgical resection (treated
with chemotherapy and radiation) 2. Non-small cell carcinoma (85%)
i. Usually amenable to surgical resection
ii. Major subtypes include adenocarcinoma (50%), squamous cell carcinoma
(30%), large cell neuroendocrine carcinoma (5%), and carcinoid tumor (5%).

63
Q

Cancers of the lung chart; small cell carcinoma; adenocarcinoma; squamous cell carcinoma, large cell neuroendocrine carcinoma; carcinoid tumor; metastasis to the lung

A
64
Q

TNM staging

A
  1. T - T u m o r size and local extension
    i. Obstruction of SVC leads to distended head and neck veins with edema and
    blue discoloration of arms and face (superior vena cava syndrome). ii. Involvement of recurrent laryngeal (hoarseness) or phrenic (diaphragmatic
    paralysis) nerve iii. Involvement of the sympathetic chain (ptosis, miosis, and anhidrosis; Horner
    syndrome) and brachial plexus (shoulder pain and hand weakness) is seen
    with apical tumors involving the superior sulcus (Pancoast tumor)
  2. N - s p r e a d to regional lymph nodes (hilar and mediastinal) 3. M - a unique site of distant metastasis is the adrenal gland. 4. Overall, 15% 5-year survival; lung carcinoma often presents late
    i. Screening by low-dose CT recommended for patients with long smoking history 5. Testing for ‘driver mutations’ guides systemic therapy in advanced disease
    i. EGFR mutations (erlotinib) or ALK translocation (crizotinib) may be present
    in adenocarcinoma; EGFR is especially common in Asian females who are non-smokers.
  3. Testing for PD-L1 expression (pembrolizumab) guides immunotherapy in
    advanced disease; PD-L1 may be present in any non-small cell carcinoma.
65
Q

pneumothorax

A

A. Accumulation of air in the pleural space
B. Spontaneous pneumothorax is due to rupture of an emphysematous bleb; seen in
young adults
1. Results in collapse of a portion of the lung (Fig. 9.24); trachea shifts to the side of
collapse.
C. Tension pneumothorax arises with penetrating chest wall injury.
1. Air enters the pleural space, but cannot exit; trachea is pushed opposite to the
side o f injury. 2. Medical emergency; treated with insertion of a chest tube

66
Q

mesothelioma

A

A. Malignant neoplasm of mesothelial cells; highly associated with occupational
exposure to asbestos
B. Presents with recurrent pleural effusions, dyspnea, and chest pain; tumor encases the
lung (Fig. 9.25).